LifeSign Rapid SARS-CoV-2 Flu A&B Antigen Combination Test Kit
Ask our experts
Description
The LifeSign Status COVID-19 Flu Influenza A & B Rapid Antigen Test is a rapid immunoassay that can be used to simultaneously detect and diagnose SARS-CoV-2, Influenza Type A, and Type B antigens. The test is quick and easy to use, with results visible in just 15 minutes. It is also highly accurate, with a sensitivity of 97.7% and a specificity of 100%. This makes it an essential tool for anyone who wants to check for the presence of these viruses. The flocked nasopharyngeal swab included with the kit ensures superior specimen collection and patient comfort. The test is Health Canada approved and has also been approved for use under FDA Emergency Use Authorization (EUA).
Features
- Visually read in 15 minutes
- Flocked nasopharyngeal swab for superior specimen collection and patient comfort
Product Specifications and Resources
| Flu A Sensitivity | 91.4%, Specificity 95.7% |
| Flu B Sensitivity | 87.6%, Specificity 95.9% |
| Test type | Lateral flow immunoassay |
| Specimen type | Nasopharyngeal (NP) swab specimen |
| Turnaround time | 15-20 minutes |
| FDA status | Emergency Use Authorization (EUA) Granted |
| CLIA complexity | Waived, Moderate, or High |
